Evaluation of gingival alterations in rats medicated with cyclosporine A, tacrolimus and sirolimus: a stereological study.

BACKGROUND AND OBJECTIVE It has previously been shown that both cyclosporine A and tacrolimus cause gingival overgrowth in the rat. We proposed that sirolimus may play an important role in decreasing the severity of gingival overgrowth. Therefore, the aim of this study was to evaluate the gingival changes induced by immunosuppressants, in the presence and absence of sirolimus, using histopathology and stereological methods. MATERIAL AND METHODS Thirty-six male Sprague-Dawley rats were distributed into six treatment groups, each containing six rats, as follows: (i) cyclosporine A for 8 wk; (ii) tacrolimus for 8 wk; (iii) sirolimus for 8 wk; (iv) cyclosporine A + sirolimus for 8 wk; (v) tacrolimus + sirolimus for 8 wk; and (vi) distilled water for 8 wk. Histomorphometric analyses included measurements of epithelial thickness and connective tissue width and height. Stereological analyses included measurements of volumetric densities of fibroblasts (Vf ), collagen fibers (Vcf ) and blood vessels (Vbv ). RESULTS Connective tissue width and height were significantly increased in cyclosporine A, tacrolimus and cyclosporine A + sirolimus groups compared with the control group (p < 0.05), and epithelial thickness was significantly increased in the cyclosporine A group and tacrolimus group compared with the control group (p < 0.05). Vf was significantly increased in the cyclosporine A group and the tacrolimus group compared with the control group (p < 0.05), whereas Vcf and Vbv were significantly increased in the cyclosporine A, tacrolimus and cyclosporine A + sirolimus groups compared with the control group (p < 0.05). CONCLUSION The results of the study suggest that sirolimus seems not to be associated with gingival overgrowth, and combined usage of sirolimus and immunosuppressants decreases the severity of gingival overgrowth.

[1]  F. Pamuk,et al.  Effects of tacrolimus and nifedipine, alone or in combination, on gingival tissues. , 2013, Journal of periodontology.

[2]  S. Uemoto,et al.  Effectiveness of sirolimus in combination with cyclosporine against chronic rejection in a pediatric liver transplant patient. , 2013, Biological & pharmaceutical bulletin.

[3]  T. Shokati,et al.  Everolimus and Sirolimus in Combination with Cyclosporine Have Different Effects on Renal Metabolism in the Rat , 2012, PloS one.

[4]  G. Franco,et al.  Gingival overgrowth in subjects under immunosuppressive regimens based on cyclosporine, tacrolimus, or sirolimus. , 2010, Journal of clinical periodontology.

[5]  D. Ramzy,et al.  Surgical biology for the clinician: vascular effects of immunosuppression. , 2010, Canadian journal of surgery. Journal canadien de chirurgie.

[6]  S. C. Cortelli,et al.  Gingival status of Brazilian renal transplant recipients under sirolimus-based regimens. , 2008, Journal of periodontology.

[7]  G. Keles,et al.  Effects of Risedronate on Alveolar Bone Loss and Angiogenesis: A Stereologic Study in Rats , 2008 .

[8]  J. S. Gutkind,et al.  Chemoprevention and treatment of experimental Cowden's disease by mTOR inhibition with rapamycin. , 2008, Cancer research.

[9]  V. Benini,et al.  Gingival overgrowth in renal transplant recipients: a study concerning prevalence, severity, periodontal, and predisposing factors. , 2008, Transplantation proceedings.

[10]  C. Shiboski,et al.  Gingival Enlargement Among Renal Transplant Recipients in the Era of New-Generation Immunosuppressants , 2008 .

[11]  F. Costa,et al.  Gingival Overgrowth in Renal Transplant Subjects Medicated With Tacrolimus in the Absence of Calcium Channel Blockers , 2008, Transplantation.

[12]  E. J. P. Lages,et al.  Demographic, pharmacologic, and periodontal variables for gingival overgrowth in subjects medicated with cyclosporin in the absence of calcium channel blockers. , 2007, Journal of periodontology.

[13]  A. Barbari,et al.  Calcineurin inhibitor-free protocols: risks and benefits. , 2007, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

[14]  Ramkumar Veppathur Mohan,et al.  mTOR Inhibition Induces Endothelial Progenitor Cell Death , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[15]  Fernando de Oliveira Costa,et al.  Prevalence, severity, and risk variables associated with gingival overgrowth in renal transplant subjects treated under tacrolimus or cyclosporin regimens. , 2006, Journal of periodontology.

[16]  L. C. Spolidorio,et al.  Oral health in renal transplant recipients administered cyclosporin A or tacrolimus. , 2006, Oral diseases.

[17]  Ashwin Prabhu,et al.  A morphologic comparison of gingival changes influenced by cyclosporin and tacrolimus in rats: an experimental study. , 2006, Journal of periodontology.

[18]  J. Bradley,et al.  Current status of renal transplantation. , 2006, Methods in molecular biology.

[19]  J. Grinyó,et al.  Calcineurin-inhibitor-sparing immunosuppressive protocols. , 2005, Transplantation proceedings.

[20]  P. Vescovi,et al.  Cyclosporin-induced gingival overgrowth: a clinical-epidemiological evaluation of 121 Italian renal transplant recipients. , 2005, Journal of periodontology.

[21]  R. Seymour,et al.  Risk factors for gingival overgrowth in patients medicated with ciclosporin in the absence of calcium channel blockers. , 2005, Journal of clinical periodontology.

[22]  A. Johnston,et al.  Novel therapies in transplantation , 2005, Expert opinion on investigational drugs.

[23]  C. Orosz,et al.  Evolution of immunosuppression in kidney transplantation: the Ohio State University experience. , 2005, Clinical transplants.

[24]  L. Mestroni,et al.  Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs. , 2004, Circulation.

[25]  F. Schena,et al.  Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal. , 2004, Journal of the American Society of Nephrology : JASN.

[26]  J. J. Taylor,et al.  Prevalence of gingival overgrowth in transplant patients immunosuppressed with tacrolimus. , 2004, Journal of clinical periodontology.

[27]  A. Dongari-Bagtzoglou.  Drug-associated gingival enlargement. , 2004, Journal of periodontology.

[28]  J. Chapman,et al.  The natural history of chronic allograft nephropathy. , 2003, The New England journal of medicine.

[29]  J. D. de Vicente,et al.  Conversion from cyclosporin A to tacrolimus as a non-surgical alternative to reduce gingival enlargement: a preliminary case series. , 2003, Journal of periodontology.

[30]  R. Calne,et al.  Bicêtre hospital experience with sirolimus-based therapy in human renal transplantation: the Sirolimus European Renal Transplant Study. , 2003, Transplantation proceedings.

[31]  S. Flechner.  Minimizing calcineurin inhibitor drugs in renal transplantation. , 2003, Transplantation proceedings.

[32]  J. Shibli,et al.  Cyclosporin A-induced gingival overgrowth in renal transplant patients. , 2003, Journal of periodontology.

[33]  D. Kelly,et al.  Investigation of the effect of FK506 (tacrolimus) and cyclosporin on gingival overgrowth following paediatric liver transplantation. , 2002, International journal of paediatric dentistry.

[34]  L. Miller.  Cardiovascular Toxicities of Immunosuppressive Agents , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[35]  P. Halloran,et al.  Late deterioration of organ transplants: a problem in injury and homeostasis. , 2002, Current opinion in immunology.

[36]  M. Carrier,et al.  Comparative study of cyclosporine and tacrolimus vs newer immunosuppressants mycophenolate mofetil and rapamycin on coronary endothelial function. , 2002, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[37]  O. Almeida,et al.  Morphological evaluation of combined effects of cyclosporin and nifedipine on gingival overgrowth in rats. , 2002, Journal of periodontal research.

[38]  P. Halloran,et al.  New developments in immunosuppressive therapy in renal transplantation , 2002, Expert opinion on biological therapy.

[39]  T. Macfarlane,et al.  Tacrolimus is not associated with gingival overgrowth in renal transplant patients. , 2001, Journal of clinical periodontology.

[40]  G. Danovitch.  Immunosuppressant-induced metabolic toxicities , 2000 .

[41]  R. Seymour,et al.  Risk factors for drug-induced gingival overgrowth. , 2000, Journal of clinical periodontology.

[42]  A. Maxwell,et al.  Reduction in gingival overgrowth associated with conversion from cyclosporin A to tacrolimus. , 2000, Journal of clinical periodontology.

[43]  J. Gummert,et al.  Newer immunosuppressive drugs: a review. , 1999, Journal of the American Society of Nephrology : JASN.

[44]  H. Gundersen,et al.  The efficiency of systematic sampling in stereology — reconsidered , 1999, Journal of microscopy.

[45]  E. Fluhler,et al.  Therapeutic blood levels of sirolimus (rapamycin) in the allografted rat. , 1996, Transplantation.

[46]  A. Matas,et al.  Prolongation Of Renal Allograft Survival In A Large Animal Model By Oral Rapamycin Monotherapy , 1995, Transplantation.

[47]  J. Djurhuus,et al.  EFFECTS OF RAPAMYCIN ON RENAL HEMODYNAMICS, WATER AND SODIUM EXCRETION, AND PLASMA LEVELS OF ANGIOTENSIN II, ALDOSTERONE, ATRIAL NATRIURETIC PEPTIDE, AND VASOPRESSIN IN PIGS , 1994, Transplantation.

[48]  B. Ryffel,et al.  Evaluation of nephrotoxicity in vitro using a suspension of highly purified porcine proximal tubular cells and characterization of the cells in primary culture. , 1994 .

[49]  B. Ryffel,et al.  Nephrotoxicity of immunosuppressants in rats: comparison of macrolides with cyclosporin. , 1994, Experimental nephrology.

[50]  J. Thliveris,et al.  THE RELATIONSHIP OF BLOOD CONCENTRATIONS OF RAPAMYCIN AND CYCLOSPORINE TO SUPPRESSION OF ALLOGRAFT REJECTION IN A RABBIT HETEROTOPIC HEART TRANSPLANT MODEL1 , 1993, Transplantation.

[51]  J. Dijoseph,et al.  THE EFFECT OF RAPAMYCIN ON KIDNEY FUNCTION IN THE SPRAGUE‐DAWLEY RAT , 1992, Transplantation.

[52]  J. Lindhe,et al.  Clinical and structural characteristics of periodontal tissues in young and old dogs. , 1991, Journal of clinical periodontology.

[53]  M. Listgarten.  Similarity of epithelial relationships in the gingiva of rat and man. , 1975, The Journal of Periodontology.